Wyeth Pharmaceuticals

New strategies are positioning MDA's research program for success

posted on January 1, 2008 - 3:06pm
The fast pace of scientific progress in this first decade of the 21st century, coupled with expanding knowledge about human genetics and disease, has led to significant changes in the way MDA approaches research.
posted on May 1, 2007 - 10:25pm
QUEST Vol. 14, No. 3
Blocking the protein known as myostatin, which limits muscle growth, has been under intense investigation as a strategy for the muscular dystrophies since 2002, when scientists found that mice with Duchenne muscular dystrophy (DMD) that were bred without myostatin were stronger and more muscular than their counterparts with normal myostatin levels.